Contact
Please use this form to send email to PR contact of this press release:
Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in Multiple Myeloma
TO:
Please use this form to send email to PR contact of this press release:
Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in Multiple Myeloma
TO: